News

Press releases

Advising UI Investissement on the acquisition of ERBC Group

De Pardieu Brocas Maffei has advised UI Investissement, a specialist in the development of unlisted French companies, in the context of the majority acquisition of the ERBC Group, alongside MACSF co-investor, and the founder and key managers.

The ERBC Group (European Research Biology Center) is a European leader in pre-clinical research and trials, present in France and Italy.

Constantly growing since its creation, the ERBC Group will benefit, with the entry of UI Investissement in its capital, of new means and expertise to implement its development project.


Last news

De Pardieu Brocas Maffei advises UI Investissement on the acquisition of a minority stake in Neftys Pharma’s share capital

Advising UI Investissement on the acquisition of a minority stake alongside Geneo Capital Entrepreneurs in the capital of Neftys Pharma, a European specialist in the distribution of veterinary [...]